Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000712729 | SCV000335982 | uncertain significance | not provided | 2015-12-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001089444 | SCV000650212 | likely benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712729 | SCV000730766 | likely benign | not provided | 2018-11-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000712729 | SCV000843251 | benign | not provided | 2019-06-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000712729 | SCV004156388 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | PLEC: BS2 |
Prevention |
RCV003947493 | SCV004769270 | likely benign | PLEC-related condition | 2020-03-23 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |